Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry announcements.
B+L Advances Two Ophthalmic Pipeline Therapies in DED and Ocular Surface Pain ...
Merck's Remigromig Meets Primary Endpoint in Phase 2b/3 BRUNELLO Trial for DME ...
Topcon Healthcare has launched Oku Digital Health, an AI-powered company focused on using ocular data to support disease detection, referrals, and pharmaceutical research Oku combines AI-supported ...
ER-100 was well tolerated through Day 56 in the first 3 patients with open-angle glaucoma, with no dose-limiting toxicities, serious adverse events, or adverse events of special interest reported Two ...
Harrow completed its acquisition of worldwide rights to Tyrvaya, excluding Japan, for $30 million upfront and up to $70 million in sales-based milestone payments The FDA-approved nasal spray expands ...
Sight Sciences has commercially launched Omni Ultra, its next-generation implant-free ab interno canaloplasty system for adult patients with primary open-angle glaucoma Omni Ultra enables single-pass ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results